Expert Review Of Pharmacoeconomics & Outcomes Research

杂志介绍

Expert Review Of Pharmacoeconomics & Outcomes Research杂志介绍

《Expert Review Of Pharmacoeconomics & Outcomes Research》是一本以English为主的未开放获取国际优秀期刊，中文名称药物经济学和结果研究专家评论，本刊主要出版、报道医学-HEALTH CARE SCIENCES & SERVICES领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE、SSCI收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为1.8，最新CiteScore 指数为4。

本刊近期中国学者发表的论文主要有：

• Cost-effectiveness of anlotinib vs. pembrolizumab and nivolumab as third-line treatment in recurrent small cell lung cancer in China

  Author: Fei, Zhengyang; Rui, Mingjun; Wang, Yingcheng; Ma, Aixia

• Economic evaluation of toripalimab plus chemotherapy compared with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma in China

  Author: Zheng, Zhiwei; Fang, Ling; Cai, Hongfu; Zhu, Huide

• Cost-effectiveness analysis of atezolizumab plus chemotherapy as first-line treatment for patients with advanced nonsquamous non-small-cell lung cancer in China

  Author: Shang, Fangjian; Zhang, Boyuan; Kang, Shuo

• Comparing measurement properties of EQ-5D and SF-6D in East and South-East Asian populations: a scoping review

  Author: Zhang, Aixue; Mao, Zhuxin; Wang, Zitong; Wu, Jing; Luo, Nan; Wang, Pei

英文介绍

Expert Review Of Pharmacoeconomics & Outcomes Research杂志英文介绍

Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review.

The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results

Article Highlights – an executive summary of the author’s most critical points.